Fujian Taifeng Pharmaceutical Chemical Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of fine chemical products such as pharmaceutical intermediates and catalysts. In 2019, it was honored as a "National High-Tech Enterprise" and a "Fujian Provincial High-Tech Enterprise." The company was established in 2011, covering an area of approximately 60 acres, with over 100 employees. It boasts a technical team composed of professionals with doctoral and master's degrees, senior engineers, and other experts, along with an excellent R&D team, advanced product testing technologies, and a comprehensive quality assurance system. In 2013, the company passed the ISO9001 "Quality Management System Certification" and has obtained multiple domestic invention patents and utility model patents.

    Since its inception, the company has consistently adhered to the business philosophy of integrity, hard work, innovation, and win-win cooperation. Upholding the corporate spirit of proactive innovation and going all out, it actively collaborates and exchanges with domestic universities and research institutions to continuously enhance its technological development and innovation capabilities. Committed to the principle of integrity first and quality supremacy, the company employs scientific management, maintains close cooperation with various sectors of society, and provides high-quality products and comprehensive services to create a better future together.

    Main products: Quinolinic acid series, 5-Amino-3-cyano-1-(2,6-dichloro-4-trifluoromethylphenyl)pyrazole, 5-Methyluridine, 1,2,3-O-Triacetyl-5-deoxy-B-D-ribose, 2’,3’-Di-O-acetyl-5-deoxy-5-fluorocytidine, 5'-Deoxy-5-fluorocytidine; 5'-Deoxyfluorocytidine; 5'-Deoxy-5-fluorocytidine nucleoside, 5'-Deoxy-5-fluoro-N-[(pentyloxy)]cytidine nucleoside, and other anticancer, antiviral pharmaceutical intermediates and pesticide intermediates.